It is reported that in tissue culture cells, the over-expression of CDK inhibitor p21Cip1 enhanced deregulated E2F activity and increased cytotoxic gene expression driven by the ARF promoter in cancer cells [164]. This evidence concerns the gene CDKN2A and cancer.